RNAC SBC to Revenue

Cartesian Therapeutics Inc · SBC to Revenue

RNAC logo

RNAC SBC to Revenue

Current (TTM)625.59%
RNAC SBC/Revenue (40.26% → 625.59%)
High-resolution chart · PNG

RNAC sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
376.153%
16.9147%
86.6174%
10.105%
9.0741%
32.6686%
0%
0%
0%
0%
0%
40.2632%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.